REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 151 filers reported holding REVANCE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,515 | -54.7% | 132 | 0.0% | 0.00% | – |
| Q2 2023 | $3,342 | -76.0% | 132 | -69.4% | 0.00% | – |
| Q1 2023 | $13,916 | +74.5% | 432 | 0.0% | 0.00% | – |
| Q4 2022 | $7,975 | -33.5% | 432 | 0.0% | 0.00% | – |
| Q3 2022 | $12,000 | +140.0% | 432 | +23.1% | 0.00% | – |
| Q2 2022 | $5,000 | -28.6% | 351 | -4.6% | 0.00% | – |
| Q1 2022 | $7,000 | -68.2% | 368 | -72.3% | 0.00% | – |
| Q4 2021 | $22,000 | +120.0% | 1,327 | +278.1% | 0.00% | – |
| Q3 2021 | $10,000 | +11.1% | 351 | +17.0% | 0.00% | – |
| Q2 2021 | $9,000 | +12.5% | 300 | 0.0% | 0.00% | – |
| Q1 2021 | $8,000 | -11.1% | 300 | 0.0% | 0.00% | – |
| Q4 2020 | $9,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,405,039 | $118,936,000 | 9.40% |
| Essex Woodlands Management, Inc. | 457,085 | $12,341,000 | 5.10% |
| Evolutionary Tree Capital Management, LLC | 191,868 | $5,180,000 | 4.98% |
| Ghost Tree Capital, LLC | 390,000 | $10,530,000 | 2.96% |
| Antara Capital LP | 4,069,400 | $109,874,000 | 2.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 896,754 | $24,212,000 | 1.40% |
| Jericho Capital Asset Management L.P. | 714,000 | $19,278,000 | 1.22% |
| Antara Capital LP | 1,600,000 | $43,200,000 | 1.14% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 120,000 | $3,240,000 | 1.04% |
| TANG CAPITAL MANAGEMENT LLC | 287,500 | $7,763,000 | 0.95% |